J&J's Rush To Market Made Mesh Patients Suffer, Jury Told
A Johnson & Johnson unit's bid to protect its market dominance by rushing a pelvic mesh implant to market without sufficient clinical testing left a Philadelphia-area woman paying the price through...To view the full article, register now.
Already a subscriber? Click here to view full article